Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 23 results.
User Information
Export Records
  1. 1.   Englerin A Inhibits EWS-FLI1 DNA Binding in Ewing Sarcoma Cells
  2. Caropreso, V.; Darvishi, E.; Turbyville, T. J.; Ratnayake, R.; Grohar, P. J.; McMahon, J. B.; Woldemichael, G. M.
  3. The Journal of biological chemistry. 2016, 6-May; 291(19): 10058-66.
  1. 2.   Farnesylated and methylated KRAS4b: high yield production of protein suitable for biophysical studies of prenylated protein-lipid interactions
  2. Gillette, W. K.; Esposito, D.; Abreu Blanco, M.; Alexander, P.; Bindu, L.; Bittner, C.; Chertov, O.; Frank, P. H.; Grose, C.; Jones, J. E.; Meng, Z.; Perkins, S.; Van, Q.; Ghirlando, R.; Fivash, M.; Nissley, D. V.; McCormick, F.; Holderfield, M.; Stephen, A. G.
  3. Scientific Reports. 2015 5: 15916.
  1. 3.   Signaling dynamics of the KSR1 scaffold complex
  2. McKay, M. M.; Ritt, D. A.; Morrison, D. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009, Jul 7; 106(27): 11022-7.
  1. 4.   Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation
  2. Puppo, M.; Pastorino, S.; Melillo, G.; Pezzolo, A.; Varesio, L.; Bosco, M. C.
  3. Clinical Cancer Research. 2004, DEC 15; 10(24): 8704-8719.
  1. 5.   Early onset hereditary papillary renal carcinoma: Germline missense mutations in the tyrosine kinase domain of the met proto-oncogene
  2. Schmidt, L. S.; Nickerson, M. L.; Angeloni, D.; Glenn, G. M.; Walther, M. M.; Albert, P. S.; Warren, M. B.; Choyke, P. L.; Torres-Cabala, C. A.; Merino, M. J.; Brunet, J.; Berez, V.; Borras, J.; Sesia, G.; Middelton, L.; Phillips, J. L.; Stolle, C.; Zbar, B.; Pautler, S. E.; Linehan, W. M.
  3. Journal of Urology. 2004, OCT; 172(4): 1256-1261.
  1. 6.   Genetic basis of cancer of the kidney: Disease specific approaches to therapy
  2. Linehan, W. M.; Vasselli, J.; Srinivasan, R.; Walther, M. M.; Merino, M.; Choyke, P.; Vocke, C.; Schmidt, L.; Isaacs, J. S.; Glenn, G.; Toro, J.; Zbar, B.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2004, SEP 15; 10(18, Part 2 Suppl. S): 6282S-6289S.
  1. 7.   Mapping and characterization of the minimal internal ribosome entry segment in the human c-myc mRNA 5 ' untranslated region
  2. Cencig, S.; Nanbru, C.; Le, S. Y.; Gueydan, C.; Huez, G.; Kruys, V.
  3. Oncogene. 2004 23(1): 267-277.
  1. 8.   Unlocking the code of 14-3-3
  2. Dougherty, M. K.; Morrison, D. K.
  3. Journal of Cell Science. 2004 117(10): 1875-1884.
  1. 9.   Studying cancer families to identify kidney cancer genes
  2. Zbar, B.; Klausner, R.; Linehan, W. M.
  3. Annual Review of Medicine-Selected Topics in the Clinical Sciences. 2003 54: 217-233.
  1. 10.   Random mutagenesis-PCR to introduce alterations into defined DNA sequences for validation of SNP and mutation detection methods
  2. Nickerson, M. L.; Warren, M. B.; Zbar, B.; Schmidt, L. S.
  3. Human Mutation. 2001 17(3): 210-219.
  1. 11.   Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: Modeling studies
  2. Miller, M.; Ginalski, K.; Lesyng, B.; Nakaigawa, N.; Schmidt, L.; Zbar, B.
  3. Proteins-Structure Function and Genetics. 2001 44(1): 32-43.
  1. 12.   Signature-based analysis of MET proto-oncogene mutations using DHPLC
  2. Nickerson, M. L.; Weirich, G.; Zbar, B.; Schmidt, L. S.
  3. Human Mutation. 2000 16(1): 68-76.
  1. 13.   Hereditary papillary renal carcinoma: pathology and pathogenesis
  2. Schmidt, L.; Lubensky, I.; Linehan, W. M.; Zbar, B.
  3. Contributions to Nephrology. 1999 128: 11-27.
  1. 14.   Primordial Germ Cells, Stem Cells and Testicular Cancer
  2. Donovan, P. J.; Demiguel, M.; Cheng, L. Z.; Resnick, J. L.
  3. APMIS. 1998 106(1): 134-141.
  1. 15.   The Germ Cell - the Mother of All Stem Cells
  2. Donovan, P. J.
  3. International Journal of Developmental Biology. 1998 42(7 Special Issue SI): 1043-1050.
  1. 16.   Identification of HGF/Met regulated genes: Implications for HGF/Met-mediated cell invasion and metastasis
  2. Taylor, G. A.; Jeffers, M.; Webb, C. P.; Vande Woude, G. F.
  3. Annual Meeting of the American Association for Cancer Research. 1997, 38 A1936.
  1. 17.   Differential effects of chemotherapeutic agents on Bcl-2/Bax apoptosis pathway in breast cancer cell
  2. Wang, T. T.
  3. Annual Meeting of the American Association for Cancer Research. 1997, 38 A769.
  1. 18.   Tpl-2 Is an Oncogenic Kinase That Is Activated By Carboxy-Terminal Truncation
  2. Ceci, J. D.; Patriotis, C. P.; Tsatsanis, C.; Makris, A. M.; Kovatch, R.; Swing, D. A.; Jenkins, N. A.; Tsichlis, P. N.; Copeland, N. G.
  3. Genes & Development. 1997 11(6): 688-700.
  1. 19.   Microinjected Cdna Encoding Jak2 Protein-Tyrosine Kinase Induces Dna Synthesis in Nih 3t3 Cells
  2. Smith, M. R.; Duhe, R. J.; Liu, Y. L.; Farrar, W. L.
  3. Febs Letters. 1997 408(3): 327-330.
  1. 20.   Reconstitution of the Nf-Kappa-B System in Saccharomyces Cerevisiae For Isolation of Effectors By Phenotype Modulation
  2. Epinat, J. C.; Whiteside, S. T.; Rice, N. R.; Israel, A.
  3. Yeast. 1997 13(7): 599-612.
  1. 21.   Inhibition of Vascular Endothelial Growth Factor-Induced Endothelial Cell Migration By Ets1 Antisense Oligonucleotides
  2. Chen, Z. Q.; Fisher, R. J.; Riggs, C. W.; Rhim, J. S.; Lautenberger, J. A.
  3. Cancer Research. 1997 57(10): 2013-2019.
  1. 22.   Gene Structure of the Human Met Proto-Oncogene
  2. Duh, F. M.; Scherer, S. W.; Tsui, L. C.; Lerman, M. I.; Zbar, B.; Schmidt, L.
  3. Oncogene. 1997 15(13): 1583-1586.
  1. 23.   Cenp-E Is an Essential Kinetochore Motor in Maturing Oocytes and Is Masked During Mos-Dependent, Cell Cycle Arrest At Metaphase Ii
  2. Duesbery, N. S.; Choi, T. S.; Brown, K. D.; Wood, K. W.; Resau, J.; Fukasawa, K.; Clevel, D. W.; Vande Woude, G. F
  3. Proceedings of the National Academy of Sciences of the United States of America. 1997 94(17): 9165-9170.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel